Vol. 3 No 1 was published on March 20, 2019. | 33 articles were submitted, 12 articles were accepted, 8 articles were rejected and 13 articles are being reviewed | Clarivate Analytics | Higher Attestation Commission of Russia | Control Committee in Education and Science of the Republic of Kazakhstan |

Ecologically safe experimental purpose application of microwaves in the treatment of chronic neurological disorders: optimization and risks

Number 2_Vol.2

AUTHORS: K. Arkhypova, A. Nosatov, M. Nurushev, P. Krasov, A. Fisun, A. Nurusheva

DOI: 10.29317/ejpfm.2018020207

PAGES: 151 - 158

DATE: 2018-06-23


Current paper describes the experimental dual-purpose application of microwaves in a controlled clinical trial on optimizing therapy for chronic neurological disorders. As a part of integrated treatment, low-intensity microwave-assisted blood modification has been used. It represents a physiotherapeutic method based on the autologous blood transfusion (self-blood treatment) after the short-term exposure to microwaves (lambda = 7.2 mm). Because of beneficial clinical impact of the microwave autohemotherapy previously observed, we aimed to find a possible way to track a manifestation of nonthermal microwave effects. For this purpose, we have applied a microwave single-frequency ( lambda = 7.6 mm) dielectrometry technique as a tool for blood sensing. Also, we used the osmotic fragility test to detect the membrane-receptor activity level using patients’ red blood cells before and after the course of therapy. Our preliminary results have shown an enhancement of blood cell reactivity and a clearly defined tendency to normalizing parameters under study in those patients who received the integrated treatment. By analyzing the data obtained by different methods, we have revealed that characteristics are well correlated.


Microwave blood sensing; microwave autohemotherapy; diagnostics; permittivity; red blood cells.


[1] M. Porcellia et al, FEBS Lett. 402(2-3) (1997) 102.
[2] S. Banik et al., Bioresource Technology 87 (2003) 155.

[3] B. Bergqvist et al., Biochim. Biophys. Acta 1201 (1994) 51.
[4] C.O. Kappe et al., Angcwandte Chemie Internat. Edit.52(4) (2013) 1088.
[5] K. Arkhypova el al., Proc.of the 44 Europ. Microwave Conf.EuMC (2014) 488.
[6] R.I. Stryuk and I.G. Dlusskaya, Adrenoreactivity and cardiovascular system
(Moscow: Meditsina, 2003) 160 p.
[7] P.S. Krasov et al., Jour. of Measur. Sci. and Instr. 2(3) (2011) 205.
[8] P.S Krasov, K.A. Arkhipova, Telecom. and Radio Engineering 68(8) (2009) 727.
[9] K.A. Arkhypova et al.,Biofizychnyi visnyk 27(2) (2011) 93 (in Russian).
[10] J.M. Steinacker, Deutsche Zeitschrift far Sportmedizin 63(11) (2012) 329.
[11] L. Tylicki et al., International Journal of Artificial Organs 24(2) (2001) 79.
[12] O.I. Belous et al., Method for EHF-autohemotherapy (Patent of Ukraine,
2007). (in Ukrainian)
[13] N.I. Sinitsyn, V.A. Elkin, Radiolekhnika 4 (2005) 86. (in Russian)
[14] O.I. Belous et al., Telecom. and Radio Engineering 67(10) (2008) 867.
[15] E.B. Almazova et al., Telecom. and Radio Engineering 71(17) (2012) 1605.
[16] K.A. Arkhypova, Telecom. and Radio Engineering 70(6) (2011) 547.
[17] I. Fellows, Journal of Statistical Software 49(8) (2012) 1.
[18] K.A. Arkhypova et al., Proc.of the Conference Modern aspects of diagnosis
and treatment the diseases of nervous system (Kyiv, 2014). (in Ukrainian)
[19] K.A. Arkhypova et al., Proc.of the 1st Congress of the European Academy of
Neurology (Berlin, 2015).

Download file Open file